1ST Source Bank reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,266 shares of the pharmacy operator’s stock after selling 51 shares during the period. 1ST Source Bank’s holdings in Walgreens Boots Alliance were worth $520,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Oppenheimer & Co. Inc. raised its position in Walgreens Boots Alliance by 24.2% in the third quarter. Oppenheimer & Co. Inc. now owns 122,952 shares of the pharmacy operator’s stock worth $9,912,000 after buying an additional 23,960 shares during the period. Intrust Bank NA raised its position in Walgreens Boots Alliance by 1.9% in the third quarter. Intrust Bank NA now owns 9,592 shares of the pharmacy operator’s stock worth $773,000 after buying an additional 175 shares during the period. Pegasus Partners Ltd. bought a new position in Walgreens Boots Alliance during the third quarter worth $250,000. M&T Bank Corp raised its position in Walgreens Boots Alliance by 2.8% in the third quarter. M&T Bank Corp now owns 375,260 shares of the pharmacy operator’s stock worth $30,254,000 after buying an additional 10,332 shares during the period. Finally, Cliftonlarsonallen Wealth Advisors LLC raised its position in Walgreens Boots Alliance by 10.7% in the third quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 14,774 shares of the pharmacy operator’s stock worth $1,191,000 after buying an additional 1,423 shares during the period. 61.32% of the stock is currently owned by hedge funds and other institutional investors.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded down 4.99% during midday trading on Friday, hitting $78.44. The company had a trading volume of 14,953,927 shares. Walgreens Boots Alliance, Inc. has a 52-week low of $76.26 and a 52-week high of $88.00. The stock has a 50 day moving average of $83.02 and a 200 day moving average of $83.80. The firm has a market cap of $84.79 billion, a price-to-earnings ratio of 20.16 and a beta of 1.20. Walgreens Boots Alliance also was the recipient of some unusual options trading on Thursday. Stock investors acquired 23,262 call options on the company. This represents an increase of approximately 320% compared to the typical daily volume of 5,535 call options.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.36. Walgreens Boots Alliance had a return on equity of 16.86% and a net margin of 3.66%. The firm had revenue of $29.45 billion for the quarter, compared to analysts’ expectations of $30.17 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The firm’s revenue for the quarter was down 2.4% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post $4.97 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 12th. Shareholders of record on Thursday, May 18th were paid a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date was Tuesday, May 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 38.36%.
ILLEGAL ACTIVITY WARNING: This news story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/06/16/1st-source-bank-sells-51-shares-of-walgreens-boots-alliance-inc-wba-updated-updated.html.
A number of equities analysts have weighed in on WBA shares. Guggenheim reissued a “buy” rating and set a $100.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, March 29th. Robert W. Baird reissued an “outperform” rating and set a $96.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, March 27th. Finally, Barclays PLC set a $79.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Saturday, April 1st. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $90.62.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the transaction, the director now owns 21,887 shares in the company, valued at $1,879,874.43. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.